IL-10 Suppression of NK/DC Crosstalk Leads to Poor Priming of MCMV-specific CD4 T Cells and Prolonged MCMV Persistence
Overview
Authors
Affiliations
IL-10 is an anti-inflammatory cytokine that regulates the extent of host immunity to infection by exerting suppressive effects on different cell types. Herpes viruses induce IL-10 to modulate the virus-host balance towards their own benefit, resulting in prolonged virus persistence. To define the cellular and molecular players involved in IL-10 modulation of herpes virus-specific immunity, we studied mouse cytomegalovirus (MCMV) infection. Here we demonstrate that IL-10 specifically curtails the MCMV-specific CD4 T cell response by suppressing the bidirectional crosstalk between NK cells and myeloid dendritic cells (DCs). In absence of IL-10, NK cells licensed DCs to effectively prime MCMV-specific CD4 T cells and we defined the pro-inflammatory cytokines IL-12, IFN-γ and TNF-α as well as NK cell activating receptors NKG2D and NCR-1 to regulate this bidirectional NK/DC interplay. Consequently, markedly enhanced priming of MCMV-specific CD4 T cells in Il10(-/-) mice led to faster control of lytic viral replication, but this came at the expense of TNF-α mediated immunopathology. Taken together, our data show that early induction of IL-10 during MCMV infection critically regulates the strength of the innate-adaptive immune cell crosstalk, thereby impacting beneficially on the ensuing virus-host balance for both the virus and the host.
Mucosal T-cell responses to chronic viral infections: Implications for vaccine design.
Al-Talib M, Dimonte S, Humphreys I Cell Mol Immunol. 2024; 21(9):982-998.
PMID: 38459243 PMC: 11364786. DOI: 10.1038/s41423-024-01140-2.
Comprehensive Analysis of Soluble Mediator Profiles in Congenital CMV Infection Using an MCMV Model.
Karner D, Kvestak D, Lisnic B, Cokaric Brdovcak M, Juranic Lisnic V, Kucan Brlic P Viruses. 2024; 16(2).
PMID: 38399983 PMC: 10891658. DOI: 10.3390/v16020208.
Clement M, Ladell K, Miners K, Marsden M, Chapman L, Cardus Figueras A Elife. 2023; 12.
PMID: 37440306 PMC: 10344424. DOI: 10.7554/eLife.79165.
Natural killer cells in COVID-19: from infection, to vaccination and therapy.
Zafarani A, Razizadeh M, Pashangzadeh S, Amirzargar M, Taghavi-Farahabadi M, Mahmoudi M Future Virol. 2023; .
PMID: 36936055 PMC: 10013930. DOI: 10.2217/fvl-2022-0040.
Mora-Bitria L, Asquith B Immunogenetics. 2023; 75(3):269-282.
PMID: 36719466 PMC: 9887252. DOI: 10.1007/s00251-023-01293-w.